Table 3.

Summary of studies of the in vitro efficacy of MB-aPDT on S. aureus.

References	Strain	Preincubation (min)	Intensity (mW/cm2)	Fluence (J/cm2)	Emission spectra λ (nm)	Concentration MB (μM)	Media	CFU/ml initial	log10 reduction
Huang et al., 2012	8325-4	30	100	8	660	20	PBS	108	6
Vecchio et al., 2015	NCTC 8325	15	ND	5	660	20	PBS	108	4
Kashef et al., 2012	ATCC 25923	30	91	163.8	660	156.32	PBS	104–105	3.1
Kashef et al., 2012	MRSA	30	91	163.8	660	156.32	PBS	104–105	2.2
Yow et al., 2011	ATCC 25923	0	ND	30	600	3	PBS	108	6.5
Yow et al., 2011	MRSA clinical	0	ND	30	600	3	PBS	108	7
Tanaka et al., 2012	MRSA clinical	0	0.040	20	665	100	HBSS	108	6.5
Nakonechny et al., 2013	ATCC 25923	15	1.6	2.88	White	30	PBS	106	6
Zeina et al., 2001	Oxford	0	42	15.12	400–700	312.65	PBS	108	5.4
Our study	ATCC 29213	0	7	18-37	625	7.6	water	107	6
Our study	ATCC 29213	0	90	37	420–700	7.6	water	107	6

MB, Methylene blue.